Uscom Ltd
ASX:UCM
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Johnson & Johnson
NYSE:JNJ
|
US |
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
US |
|
Bank of America Corp
NYSE:BAC
|
US |
|
Mastercard Inc
NYSE:MA
|
US |
|
UnitedHealth Group Inc
NYSE:UNH
|
US |
|
Exxon Mobil Corp
NYSE:XOM
|
US |
|
Pfizer Inc
NYSE:PFE
|
US |
|
Nike Inc
NYSE:NKE
|
US |
|
Visa Inc
NYSE:V
|
US |
|
Alibaba Group Holding Ltd
NYSE:BABA
|
CN |
|
JPMorgan Chase & Co
NYSE:JPM
|
US |
|
Coca-Cola Co
NYSE:KO
|
US |
|
Verizon Communications Inc
NYSE:VZ
|
US |
|
Chevron Corp
NYSE:CVX
|
US |
|
Walt Disney Co
NYSE:DIS
|
US |
|
PayPal Holdings Inc
NASDAQ:PYPL
|
US |
Uscom Ltd
Other Operating Expenses
Uscom Ltd
Other Operating Expenses Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
| Company | Other Operating Expenses | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
|---|---|---|---|---|---|---|
|
|
Uscom Ltd
ASX:UCM
|
Other Operating Expenses
N/A
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
Somnomed Ltd
ASX:SOM
|
Other Operating Expenses
N/A
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
Cochlear Ltd
ASX:COH
|
Other Operating Expenses
AU$21m
|
CAGR 3-Years
16%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
19%
|
|
|
Optiscan Imaging Ltd
ASX:OIL
|
Other Operating Expenses
AU$1.7m
|
CAGR 3-Years
20%
|
CAGR 5-Years
9%
|
CAGR 10-Years
4%
|
|
|
Austco Healthcare Ltd
ASX:AHC
|
Other Operating Expenses
-AU$4.8m
|
CAGR 3-Years
-35%
|
CAGR 5-Years
-36%
|
CAGR 10-Years
N/A
|
|
|
EMvision Medical Devices Ltd
ASX:EMV
|
Other Operating Expenses
N/A
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
Uscom Ltd
Glance View
Uscom Ltd. engages in the development, design, manufacture, and marketing of non-invasive cardiovascular and pulmonary medical devices. The company is headquartered in Sydney, New South Wales. The company went IPO on 2003-12-10. The firm manages a network of distribution partners across the world for the sale of its equipment to hospitals and other medical care locations. Its geographic segments include Singapore, Australia, China, South East Asia, Europe and the United States. The firm has approximately three practice suites of devices in the field of cardiac, vascular and pulmonary monitoring, including the USCOM 1A, which is an hemodynamic monitor that measures cardiovascular function, detects irregularities and is used to guide treatment, USCOM BP+, which is a supra systolic oscillometric Central Blood Pressure monitor that measures blood pressure and blood pressure waveforms only previously available using cardiac catheterization, and the Uscom SpiroSonic spirometers, which is a digital pulmonary testing device.
